BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23994681)

  • 1. Trans/cis isomerization of [RuCl2{H2C=C(CH2PPh2)2)}(diamine)] complexes: synthesis, spectral, crystal structure and DFT calculations and catalytic activity in the hydrogenation of α,β-unsaturated ketones.
    Warad I; Al-Noaimi M; Abdel-Rahman OS; Awwadi FF; Hammouti B; Hadda TB
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 117():250-8. PubMed ID: 23994681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. trans-Fe(II)(H)2(diphosphine)(diamine) complexes as alternative catalysts for the asymmetric hydrogenation of ketones? A DFT study.
    Chen HY; Di Tommaso D; Hogarth G; Catlow CR
    Dalton Trans; 2011 Jan; 40(2):402-12. PubMed ID: 21103602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans/cis isomerization of [RuCl2(diphosphine)(diamine)] complexes: synthesis, X-ray structure and catalytic activity in hydrogenation.
    Warad I; AlHussen H; Alanazi H; Mahfouz R; Hammouti B; Al-Dosari MA; Al-Far R; Ben Hadda T
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():466-73. PubMed ID: 23348199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium(II) bipyridine complexes bearing new keto-enol azoimine ligands: synthesis, structure, electrochemistry and DFT calculations.
    Al-Noaimi M; Awwadi FF; Mansi A; Abdel-Rahman OS; Hammoudeh A; Warad I
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():828-39. PubMed ID: 25150434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium(II) complexes containing bis(2-(diphenylphosphino)phenyl) ether and their catalytic activity in hydrogenation reactions.
    Venkateswaran R; Mague JT; Balakrishna MS
    Inorg Chem; 2007 Feb; 46(3):809-17. PubMed ID: 17257024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterotrimetallic Ru(II)/Pd(II)/Ru(II) complexes: synthesis, crystalstructure, spectral characterization, DFT calculation and antimicrobial study.
    Al-Noaimi M; Nafady A; Warad I; Alshwafy R; Husein A; Talib WH; Hadda TB
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():273-82. PubMed ID: 24316542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
    Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
    Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, characterization of novel ruthenium(II) catalysts: highly efficient and selective hydrogenation of cinnamaldehyde to (E)-3-phenylprop-2-en-1-ol.
    Darwish HW; Barakat A; Nafady A; Suleiman M; Al-Noaimi M; Hammouti B; Radi S; Hadda TB; Abu-Obaid A; Mubarak MS; Warad I
    Molecules; 2014 May; 19(5):5965-80. PubMed ID: 24818576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral eta(6)-arene/N-tosylethylenediamine-ruthenium(II) complexes: solution behavior and catalytic activity for asymmetric hydrogenation.
    Sandoval CA; Bie F; Matsuoka A; Yamaguchi Y; Naka H; Li Y; Kato K; Utsumi N; Tsutsumi K; Ohkuma T; Murata K; Noyori R
    Chem Asian J; 2010 Apr; 5(4):806-16. PubMed ID: 20235268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, spectral, thermal, X-ray single crystal of new RuCl₂(dppb)diamine complexes and their application in hydrogenation of Cinnamic aldehyde.
    Warad I; Al-Hussain H; Al-Far R; Mahfouz R; Hammouti B; Hadda TB
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Sep; 95():374-81. PubMed ID: 22554619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational study of the factors controlling enantioselectivity in ruthenium(II) hydrogenation catalysts.
    Di Tommaso D; French SA; Zanotti-Gerosa A; Hancock F; Palin EJ; Catlow CR
    Inorg Chem; 2008 Apr; 47(7):2674-87. PubMed ID: 18318476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, DNA binding and catalytic applications of Ru(III) complexes.
    Shoair AF; El-Shobaky AR; Azab EA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 151():322-34. PubMed ID: 26143325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New chiral catalysts for reduction of ketones.
    Gao JX; Zhang H; Yi XD; Xu PP; Tang CL; Wan HL; Tsai KR; Ikariya T
    Chirality; 2000 Jun; 12(5-6):383-8. PubMed ID: 10824157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and reactivity of ruthenium diene/diamine complexes including catalytic hydrogenation of ketones.
    Morilla ME; Rodríguez P; Belderrain TR; Graiff C; Tiripicchio A; Nicasio MC; Pérez PJ
    Inorg Chem; 2007 Oct; 46(22):9405-14. PubMed ID: 17900107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, spectral and catalytic dehydrogenation studies of ruthenium complexes containing NO bidentate ligands.
    Shoair AF; El-Bindary AA
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Oct; 131():490-6. PubMed ID: 24840490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic structures of ruthenium and osmium complexes of 9,10-phenanthrenequinone.
    Biswas MK; Patra SC; Maity AN; Ke SC; Adhikary ND; Ghosh P
    Inorg Chem; 2012 Jun; 51(12):6687-99. PubMed ID: 22663598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.
    Cánaves MM; Cabra MI; Bauzá A; Cañellas P; Sánchez K; Orvay F; García-Raso A; Fiol JJ; Terrón A; Barceló-Oliver M; Ballester P; Mata I; Molins E; Hussain F; Frontera A
    Dalton Trans; 2014 May; 43(17):6353-64. PubMed ID: 24599509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
    Reisner E; Arion VB; Eichinger A; Kandler N; Giester G; Pombeiro AJ; Keppler BK
    Inorg Chem; 2005 Sep; 44(19):6704-16. PubMed ID: 16156629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective synthesis of 3,4-disubstituted cis- and trans-1,2,5-thiadiazolidine-1,1-dioxides as precursors for chiral 1,2-diamines.
    Schüttler C; Li-Böhmer Z; Harms K; von Zezschwitz P
    Org Lett; 2013 Feb; 15(4):800-3. PubMed ID: 23346962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ligand variation on enantioselective hydrogenation catalysed by RuH2(diphosphine)(diamine) complexes.
    Chen HY; Di Tommaso D; Hogarth G; Catlow CR
    Dalton Trans; 2012 Feb; 41(6):1867-77. PubMed ID: 22166917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.